3 March 2023
Latham & Watkins Advises on Option Care Health’s Secondary Offering of Common Stock and Common Stock Repurchase
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Michael Benjamin Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Adam Gelardi Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Simon Cooke | Latham & Watkins LLP | Associate | capital markets | New York |
| Ian Lachow | Latham & Watkins LLP | Associate | capital markets | New York |
| Jiyeon Lee-Lim | Latham & Watkins LLP | Partner | tax | Not stated |
| Michael Syku | Latham & Watkins LLP | Associate | tax | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 30.8 (US$30.75 per share)
- What the figure measures
- Per share
- Client
- Not stated
- Counterparties
- Option Care Health, Inc. (Issuer)
Walgreens Boots Alliance, Inc. (Sell-side)